These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9028333)

  • 1. Defective transport is a common mechanism of acquired methotrexate resistance in acute lymphocytic leukemia and is associated with decreased reduced folate carrier expression.
    Gorlick R; Goker E; Trippett T; Steinherz P; Elisseyeff Y; Mazumdar M; Flintoff WF; Bertino JR
    Blood; 1997 Feb; 89(3):1013-8. PubMed ID: 9028333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of methotrexate resistance in acute leukemia. Decreased transport and polyglutamylation.
    Gorlick R; Cole P; Banerjee D; Longo G; Li WW; Hochhauser D; Bertino JR
    Adv Exp Med Biol; 1999; 457():543-50. PubMed ID: 10500832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced folate carrier expression in acute lymphoblastic leukemia: a mechanism for ploidy but not lineage differences in methotrexate accumulation.
    Belkov VM; Krynetski EY; Schuetz JD; Yanishevski Y; Masson E; Mathew S; Raimondi S; Pui CH; Relling MV; Evans WE
    Blood; 1999 Mar; 93(5):1643-50. PubMed ID: 10029593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable expression of RFC1 in human leukemia cell lines resistant to antifolates.
    Kobayashi H; Takemura Y; Ohnuma T
    Cancer Lett; 1998 Feb; 124(2):135-42. PubMed ID: 9500202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective transport as a mechanism of acquired resistance to methotrexate in patients with acute lymphocytic leukemia.
    Trippett T; Schlemmer S; Elisseyeff Y; Goker E; Wachter M; Steinherz P; Tan C; Berman E; Wright JE; Rosowsky A
    Blood; 1992 Sep; 80(5):1158-62. PubMed ID: 1381235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced folate carrier gene expression in childhood acute lymphoblastic leukemia: relationship to immunophenotype and ploidy.
    Zhang L; Taub JW; Williamson M; Wong SC; Hukku B; Pullen J; Ravindranath Y; Matherly LH
    Clin Cancer Res; 1998 Sep; 4(9):2169-77. PubMed ID: 9748136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of carrier-mediated transport of folates and antifolates in methotrexate-sensitive and-resistant leukemia cells.
    Jansen G; Mauritz RM; Assaraf YG; Sprecher H; Drori S; Kathmann I; Westerhof GR; Priest DG; Bunni M; Pinedo HM; Schornagel JH; Peters GJ
    Adv Enzyme Regul; 1997; 37():59-76. PubMed ID: 9381986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistance.
    Jansen G; Mauritz R; Drori S; Sprecher H; Kathmann I; Bunni M; Priest DG; Noordhuis P; Schornagel JH; Pinedo HM; Peters GJ; Assaraf YG
    J Biol Chem; 1998 Nov; 273(46):30189-98. PubMed ID: 9804775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced folate carrier mutations are not the mechanism underlying methotrexate resistance in childhood acute lymphoblastic leukemia.
    Kaufman Y; Drori S; Cole PD; Kamen BA; Sirota J; Ifergan I; Arush MW; Elhasid R; Sahar D; Kaspers GJ; Jansen G; Matherly LH; Rechavi G; Toren A; Assaraf YG
    Cancer; 2004 Feb; 100(4):773-82. PubMed ID: 14770434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired membrane transport in methotrexate-resistant CCRF-CEM cells involves early translation termination and increased turnover of a mutant reduced folate carrier.
    Wong SC; Zhang L; Witt TL; Proefke SA; Bhushan A; Matherly LH
    J Biol Chem; 1999 Apr; 274(15):10388-94. PubMed ID: 10187828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced folate carrier and dihydrofolate reductase expression in acute lymphocytic leukemia may predict outcome: a Children's Cancer Group Study.
    Levy AS; Sather HN; Steinherz PG; Sowers R; La M; Moscow JA; Gaynon PS; Uckun FM; Bertino JR; Gorlick R;
    J Pediatr Hematol Oncol; 2003 Sep; 25(9):688-95. PubMed ID: 12972803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-amino-4-imidazolecarboxamide riboside potentiates both transport of reduced folates and antifolates by the human reduced folate carrier and their subsequent metabolism.
    McGuire JJ; Haile WH; Yeh CC
    Cancer Res; 2006 Apr; 66(7):3836-44. PubMed ID: 16585211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Confocal microscopy visualization of antifolate uptake by the reduced folate carrier in human leukaemic cells.
    Jolivet J; Faure MP; Wong SC; Taub JW; Matherly LH
    Br J Cancer; 1997; 76(6):734-8. PubMed ID: 9310238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated dihydrofolate reductase and impaired methotrexate transport as elements in methotrexate resistance in childhood acute lymphoblastic leukemia.
    Matherly LH; Taub JW; Ravindranath Y; Proefke SA; Wong SC; Gimotty P; Buck S; Wright JE; Rosowsky A
    Blood; 1995 Jan; 85(2):500-9. PubMed ID: 7812005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced folate carrier gene (RFC1) expression and anti-folate resistance in transfected and non-selected cell lines.
    Moscow JA; Connolly T; Myers TG; Cheng CC; Paull K; Cowan KH
    Int J Cancer; 1997 Jul; 72(1):184-90. PubMed ID: 9212241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple mechanisms of resistance to methotrexate and novel antifolates in human CCRF-CEM leukemia cells and their implications for folate homeostasis.
    Mauritz R; Peters GJ; Priest DG; Assaraf YG; Drori S; Kathmann I; Noordhuis P; Bunni MA; Rosowsky A; Schornagel JH; Pinedo HM; Jansen G
    Biochem Pharmacol; 2002 Jan; 63(2):105-15. PubMed ID: 11841783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrasting effects of oncogene expression on two carrier-mediated systems internalizing folate compounds in Fisher rat 3T3 cells.
    Kühnel JM; Chiao JH; Sirotnak FM
    J Cell Physiol; 2000 Sep; 184(3):364-72. PubMed ID: 10911368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and epigenetic alterations of the reduced folate carrier in untreated diffuse large B-cell lymphoma.
    Kastrup IB; Worm J; Ralfkiaer E; Hokland P; Guldberg P; Grønbaek K
    Eur J Haematol; 2008 Jan; 80(1):61-6. PubMed ID: 18028428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between folate transport activity at low pH and reduced folate carrier function in human Huh7 hepatoma cells.
    Zhao R; Hanscom M; Goldman ID
    Biochim Biophys Acta; 2005 Aug; 1715(1):57-64. PubMed ID: 16109384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of the human folate receptor mediates transport-defective methotrexate resistance in KB cells.
    Saikawa Y; Knight CB; Saikawa T; Page ST; Chabner BA; Elwood PC
    J Biol Chem; 1993 Mar; 268(7):5293-301. PubMed ID: 7680349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.